Pharmaceutical Reason Knowledge and Value in Global Psychiatry

An arresting case-study highlighting the social and political implications of a new ???pharmaceutical??? way of thinking about human behaviour.

Andrew Lakoff argues that a new 'pharmaceutical' way of thinking about and acting upon mental disorder is coming to reshape not only the field of psychiatry, but also our very notions of self. Drawing from a comprehensive ethnography of psychiatric practice in Argentina (a country which boasts the most psychoanalysts per capita in the world) Lakoff looks at new ways of understanding and intervening in human behaviour. He charts the globalization of pharmacology, particularily the global impact of US psychiatry and US models of illness, and further illustrates the clashes, conflicts, alliances and reformulations that take place when psychoanalytic and psychopharmacological models of illness and cure meet. Highlighting the social and political implications that these new forms of expertise about human behaviour and human thought bring, Lakoff presents an arresting case-study that will appeal to scholars and students alike.

Introduction: specific effects; 1. Diagnostic liquidity; 2. Medicating the symptom; 3. The Lacan ward; 4. Living with neuroscience; 5. The private life of numbers; Conclusion: the segmented phenotype.

Lakoff presents an arresting case-study highlighting the social and political implications of a new 'pharmaceutical' way of thinking about and acting upon human behaviour and human thought. Drawing from a comprehensive ethnography of psychiatric practice in Argentina, this will appeal beyond psychiatry and the life sciences.

Dr Andrew Lakoff is an Assistant Professor of Sociology and Science Studies at the University of California, San Diego. He is co-editor, with Adriana Petryna and Arthur Kleinman of Global Pharmaceuticals: Ethics, Markets, Practices (2006).